Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Medina

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Recent Patents on CNS Drug Discovery|December 2, 2010
Recent developments in tau-based therapeutics for neurodegenerative diseasesMiguel Medina
Springerplus|April 9, 2016
Recent developments in tau-based therapeutics for Alzheimer's disease and related dementsiaMiguel Medina
JAAPA : Official Journal of the American Academy of Physician Assistants|April 29, 2016
What is causing this man's persistent low back pain?Miguel Medina
International Journal of Molecular Sciences|April 12, 2018
An Overview on the Clinical Development of Tau-Based TherapeuticsMiguel Medina
Expert Review of Neurotherapeutics|January 4, 2015
Further understanding of tau phosphorylation: implications for therapyMiguel Medina, Jesús Avila
International Journal of Alzheimer'S Disease|June 2, 2011
Deconstructing GSK-3: The Fine Regulation of Its ActivityMiguel Medina, Francisco Wandosell
Current Pharmaceutical Design|August 12, 2010
Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's diseaseMiguel Medina, Jesús Avila
Current Opinion in Drug Discovery & Development|July 5, 2008
Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinicMiguel Medina, Ana Castro
Frontiers in Pharmacology|November 12, 2014
The need for better AD animal modelsMiguel Medina, Jesús Avila
Frontiers in Cellular Neuroscience|May 6, 2014
The role of extracellular Tau in the spreading of neurofibrillary pathologyMiguel Medina, Jesús Avila
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Recent Patents on CNS Drug Discovery|December 2, 2010
Recent developments in tau-based therapeutics for neurodegenerative diseasesMiguel Medina
Springerplus|April 9, 2016
Recent developments in tau-based therapeutics for Alzheimer's disease and related dementsiaMiguel Medina
JAAPA : Official Journal of the American Academy of Physician Assistants|April 29, 2016
What is causing this man's persistent low back pain?Miguel Medina
International Journal of Molecular Sciences|April 12, 2018
An Overview on the Clinical Development of Tau-Based TherapeuticsMiguel Medina
Expert Review of Neurotherapeutics|January 4, 2015
Further understanding of tau phosphorylation: implications for therapyMiguel Medina, Jesús Avila
International Journal of Alzheimer'S Disease|June 2, 2011
Deconstructing GSK-3: The Fine Regulation of Its ActivityMiguel Medina, Francisco Wandosell
Current Pharmaceutical Design|August 12, 2010
Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's diseaseMiguel Medina, Jesús Avila
Current Opinion in Drug Discovery & Development|July 5, 2008
Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinicMiguel Medina, Ana Castro
Frontiers in Pharmacology|November 12, 2014
The need for better AD animal modelsMiguel Medina, Jesús Avila
Frontiers in Cellular Neuroscience|May 6, 2014
The role of extracellular Tau in the spreading of neurofibrillary pathologyMiguel Medina, Jesús Avila
Pageof 16